179 related articles for article (PubMed ID: 32325111)
1. Bisphenol A induces focal adhesions assembly and activation of FAK, Src and ERK2 via GPER in MDA-MB-231 breast cancer cells.
Castillo-Sanchez R; Ramirez-Ricardo J; Martinez-Baeza E; Cortes-Reynosa P; Candanedo-Gonzales F; Gomez R; Salazar EP
Toxicol In Vitro; 2020 Aug; 66():104871. PubMed ID: 32325111
[TBL] [Abstract][Full Text] [Related]
2. Bisphenol A Induces Migration through a GPER-, FAK-, Src-, and ERK2-Dependent Pathway in MDA-MB-231 Breast Cancer Cells.
Castillo Sanchez R; Gomez R; Perez Salazar E
Chem Res Toxicol; 2016 Mar; 29(3):285-95. PubMed ID: 26914403
[TBL] [Abstract][Full Text] [Related]
3. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
[TBL] [Abstract][Full Text] [Related]
4. Bisphenol A increases the size of primary mammary tumors and promotes metastasis in a murine model of breast cancer.
Torres-Alamilla P; Castillo-Sanchez R; Cortes-Reynosa P; Gomez R; Perez Salazar E
Mol Cell Endocrinol; 2023 Sep; 575():111998. PubMed ID: 37414130
[TBL] [Abstract][Full Text] [Related]
5. Bisphenol A Increases the Migration and Invasion of Triple-Negative Breast Cancer Cells via Oestrogen-related Receptor Gamma.
Zhang XL; Liu N; Weng SF; Wang HS
Basic Clin Pharmacol Toxicol; 2016 Oct; 119(4):389-95. PubMed ID: 27038254
[TBL] [Abstract][Full Text] [Related]
6. Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts.
Pupo M; Pisano A; Lappano R; Santolla MF; De Francesco EM; Abonante S; Rosano C; Maggiolini M
Environ Health Perspect; 2012 Aug; 120(8):1177-82. PubMed ID: 22552965
[TBL] [Abstract][Full Text] [Related]
7. Bisphenol A induces proliferative effects on both breast cancer cells and vascular endothelial cells through a shared GPER-dependent pathway in hypoxia.
Xu F; Wang X; Wu N; He S; Yi W; Xiang S; Zhang P; Xie X; Ying C
Environ Pollut; 2017 Dec; 231(Pt 2):1609-1620. PubMed ID: 28964603
[TBL] [Abstract][Full Text] [Related]
8. Bisphenol A stimulates human lung cancer cell migration via upregulation of matrix metalloproteinases by GPER/EGFR/ERK1/2 signal pathway.
Zhang KS; Chen HQ; Chen YS; Qiu KF; Zheng XB; Li GC; Yang HD; Wen CJ
Biomed Pharmacother; 2014 Oct; 68(8):1037-43. PubMed ID: 25312822
[TBL] [Abstract][Full Text] [Related]
9. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
10. Bisphenol A and Related Alkylphenols Exert Nongenomic Estrogenic Actions Through a G Protein-Coupled Estrogen Receptor 1 (Gper)/Epidermal Growth Factor Receptor (Egfr) Pathway to Inhibit Meiotic Maturation of Zebrafish Oocytes.
Fitzgerald AC; Peyton C; Dong J; Thomas P
Biol Reprod; 2015 Dec; 93(6):135. PubMed ID: 26490843
[TBL] [Abstract][Full Text] [Related]
11. Bisphenol A triggers proliferation and migration of laryngeal squamous cell carcinoma via GPER mediated upregulation of IL-6.
Li S; Wang B; Tang Q; Liu J; Yang X
Cell Biochem Funct; 2017 Jun; 35(4):209-216. PubMed ID: 28466560
[TBL] [Abstract][Full Text] [Related]
12. GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells.
Deng Q; Jiang G; Wu Y; Li J; Liang W; Chen L; Su Q; Li W; Du J; Wong CKC; Chen Z; Wang H
J Hazard Mater; 2018 Aug; 355():1-9. PubMed ID: 29758456
[TBL] [Abstract][Full Text] [Related]
13. Involvement of estrogen receptor and GPER in bisphenol A induced proliferation of vascular smooth muscle cells.
Gao F; Huang Y; Zhang L; Liu W
Toxicol In Vitro; 2019 Apr; 56():156-162. PubMed ID: 30677511
[TBL] [Abstract][Full Text] [Related]
14. Bisphenol AF and Bisphenol B Exert Higher Estrogenic Effects than Bisphenol A via G Protein-Coupled Estrogen Receptor Pathway.
Cao LY; Ren XM; Li CH; Zhang J; Qin WP; Yang Y; Wan B; Guo LH
Environ Sci Technol; 2017 Oct; 51(19):11423-11430. PubMed ID: 28858478
[TBL] [Abstract][Full Text] [Related]
15. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
16. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals.
Chen ZJ; Wei W; Jiang GM; Liu H; Wei WD; Yang X; Wu YM; Liu H; Wong CK; Du J; Wang HS
Mol Oncol; 2016 Jun; 10(6):775-88. PubMed ID: 26842883
[TBL] [Abstract][Full Text] [Related]
17. DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer.
Awada Z; Nasr R; Akika R; Cahais V; Cuenin C; Zhivagui M; Herceg Z; Ghantous A; Zgheib NK
Clin Epigenetics; 2019 Oct; 11(1):138. PubMed ID: 31601247
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA Inhibits Triple-Negative Breast Cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) Dependent Signaling Pathway.
He Y; Yang K; Liu J; Shi D; Zhang Z; Yang J; Chen M; Zhao P
Dis Markers; 2023; 2023():8371623. PubMed ID: 36741908
[TBL] [Abstract][Full Text] [Related]
19. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
[TBL] [Abstract][Full Text] [Related]
20. The G protein-coupled estrogen receptor-1, GPER-1, promotes fibrillogenesis via a Shc-dependent pathway resulting in anchorage-independent growth.
Magruder HT; Quinn JA; Schwartzbauer JE; Reichner J; Huang A; Filardo EJ
Horm Cancer; 2014 Dec; 5(6):390-404. PubMed ID: 25096985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
